Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2006-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.CCA.2006.01.024PMID 16507303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissue of atherosclerotic rabbits.

  2004cited by this paper
• Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells

  2003cited by this paper
• Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease.

  2003cited by this paper
• Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.

  2003cited by this paper
• Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaques.

  2002cited by this paper
• HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins

  2002cited by this paper
• Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells.

  2001cited by this paper
• Angiotensin II and Its Metabolites Stimulate PAI-1 Protein Release From Human Adipocytes in Primary Culture

  2001cited by this paper
• Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver.

  2001cited by this paper
• Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes.

  2001cited by this paper
• Ceiling culture of mature human adipocytes: use in studies of adipocyte functions.

  2000cited by this paper
• Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells.

  2000cited by this paper
• The Fat Mouse: A Powerful Genetic Model to Study Hemostatic Gene Expression in Obesity/NIDDM

  2000cited by this paper
• Pravastatin: An Antithrombotic Effect Independent of the Cholesterol-lowering Effect

  2000cited by this paper
• HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells.

  2000cited by this paper
• Non—Lipid-lowering effects of statins on atherosclerosis

  1999cited by this paper
• The adipocyte and hemostatic balance in obesity: studies of PAI-1.

  1998cited by this paper
• Expression of Fibrinolytic Genes in Tissues from Human Atherosclerotic Aneurysms and from Obese Mice

  1997cited by this paper
• Tissue Distribution and Regulation of Plasminogen Activator Inhibitor-1 in Obese Mice

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper

• Adipose-PAS interactions in the context of its localised bio-engineering potential (Review)

  2021cites this paper
• Statins Increase Plasminogen Activator Inhibitor Type 1 Gene Transcription through a Pregnane X Receptor Regulated Element

  2015cites this paper
• Adipose tissue, inflammation and atherosclerosis

  2014cites this paper
• Most appropriate animal models to study the efficacy of statins: a systematic review

  2014cites this paper
• Statins for sepsis: distinguishing signal from the noise when designing clinical trials.

  2013cites this paper
• Reply: No indication that mineral wool causes mesothelioma.

  2013cites this paper
• Concomitant Administration of Different Doses of Simvastatin with Ivabradine Influence on PAI-1 and Heart Rate in Normo- and Hypercholesterolaemic Rats

  2012cites this paper
• Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products.

  2011cites this paper
• Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes

  2011cites this paper
• Up-regulating PPAR-γ expression and NO concentration, and down-regulating PAI-1 concentration in a rabbit atherosclerotic model: the possible antiatherogenic and antithrombotic effects of atorvastatin.

  2010cites this paper
• Effect of Atorvastatin Versus Rosuvastatin on Levels of Serum Lipids, Inflammatory Markers and Adiponectin in Patients with Hypercholesterolemia

  2009cites this paper
• Models to study atherosclerosis: a mechanistic insight.

  2009cites this paper
• Stress-induced PAI-1 expression is suppressed by pitavastatin in vivo

  2009cites this paper
• A novel cholesterol absorption inhibitor, ezetimibe, decreases adipose-derived and vascular PAI-1 expression in vivo.

  2009cites this paper
• Effects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death

  2009cites this paper
• The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes.

  2008cites this paper
• Regulatio no fp lasminoge na ctivato ri nhibito rt ype 1g ene expression by inflammatory mediator sa nd statins

  2008cites this paper
• Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins

  2008cites this paper
• Direct adipotropic actions of atorvastatin: differentiation state-dependent induction of apoptosis, modulation of endocrine function, and inhibition of glucose uptake.

  2007cites this paper
• The adipose tissue as an endocrine organ--a nephrologists' perspective.

  2006cites this paper